ICCO.US InterCare DX Inc
- Market cap
- USD 7.43K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2023.
Is ICCO.US undervalued?
Graham numberThe Graham number of InterCare DX Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
InterCare DX Inc fundamental analysis
No fundamental analysis for InterCare DX Inc yet.
InterCare DX Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About InterCare DX Inc
InterCare DX, Inc. operates as a biomedical and other software products development and services company. It creates, publishes, and markets software products that are embedded with sound, text, and video for relaxation training and stress management. The company also develops an integrated Internet-ready and RFID enabled applications, which target education, hospitality, legal system, human capital, and healthcare industry markets. Its products comprise e-Learning Integrate…
Full company profileInterCare DX Inc financial statements
2023 annualized: Fiscal year 2023 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2023, the balance sheet is the latest quarter. Figures change when the annual report is published.
InterCare DX Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2003 | 2004 | 2005 | 2006 | 2020 | 2021 | 2022 | 2023 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0.00 | 0.00 | 12.0K | 1.64M | - | - | - | - |
| Gross Profit | 0.00 | 0.00 | -106K | 256K | -275.00 | -285.00 | -298.00 | -307.44 |
| Operating Income | -302K | -215K | -277K | 129K | -650.00 | -645.00 | -789.00 | -737.40 |
| EBITDA | - | - | - | - | 0.30 | 0.63 | 0.33 | 737.40 |
| Net Income | -302K | -215K | -277K | 130K | -651.00 | -645.00 | -789.00 | -737.40 |
| EPS | - | - | - | - | -0.01 | -0.01 | -0.01 | -0.01 |
| Balance Sheet | ||||||||
| Total Assets | 1.50M | 1.50M | 1.39M | 59.1K | - | 0.09 | 0.07 | 0.22 |
| Total Liabilities | 1.55M | 1.70M | 1.68M | 139K | 3.65K | 4.28K | 5.07K | 5.44K |
| Shareholders' Equity | -48.4K | -202K | -281K | -79.5K | -3.65K | -4.28K | -5.07K | -5.44K |
| Cash & Short-term Investments | 525.00 | 2.13K | 147.00 | 4.38K | - | 0.09 | 0.07 | 0.22 |
| Total Debt | - | - | - | - | 3.63K | 4.27K | 5.06K | 5.42K |
| Cash Flow | ||||||||
| Operating Cash Flow | -23.4K | -122K | -112K | 89.9K | -644.00 | -645.00 | -789.00 | -706.80 |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | - | - | - | - | -644.00 | -645.00 | -789.00 | -706.80 |
| Ratios | ||||||||
| ROA | -20.1% | -14.3% | -19.8% | 219.3% | - | -716,666.7% | -1,127,142.9% | -335,181.8% |
| Net Profit Margin | - | - | -2,303.7% | 7.9% | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
InterCare DX Inc dividends
InterCare DX Inc has not paid dividends in the last 7 fiscal years.
Who owns InterCare DX Inc
Ownership data of InterCare DX Inc is not available yet.
InterCare DX Inc company profile
- Company name
- InterCare DX Inc
- Ticker
- ICCO.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Technology
- Fiscal year end
- December
- Address
- 20280 South Vermont Avenue, Torrance, CA, United States, 90502
- Phone
- 866-767-4832
- Website
- intercare.com
About InterCare DX Inc
InterCare DX, Inc. operates as a biomedical and other software products development and services company. It creates, publishes, and markets software products that are embedded with sound, text, and video for relaxation training and stress management. The company also develops an integrated Internet-ready and RFID enabled applications, which target education, hospitality, legal system, human capital, and healthcare industry markets. Its products comprise e-Learning Integrated Technology Enterprise Systems for integrated tuition, boarding and lodging management, enterprise vendor portal, customer relationship management, enterprise budgeting, and financial management, as well as other tools used in administering education at all levels; InterCare Clinical Explorer, a software application designed to integrate virtually all aspects of the healthcare enterprise; and InterCare Vascular Diagnostic Center to measure vascular health in patients before exhibiting symptoms. The company was formerly known as InterCare Diagnostics. InterCare DX, Inc. was founded in 1991 and is based in Torrance, California. InterCare DX, Inc.is a subsidiary of Meridian Holdings, Inc.
InterCare DX Inc management
5- Dr. Anthony C. Dike FACP, M.D.Founder, Chairman, CEO, CFO, Secretary, Treasurer and Member of the Clinical Advisory Board · born 1955
- Mr. Jerry Miller MBAInterim President and Interim Chief Operations Officer · born 1956
- Mr. Russ A. Lyon MAChief Technology Officer · born 1949
- Mr. Kenneth JohnsonVice President of Business Development and Vice President of Finance
- Mr. Donald L. StanfordChief Technical Strategist and Director · born 1951